Idéal Investisseur
Français English
CAC 40 : Market closed
7 962,48 pts
-0.09%


Last updated : 30/10/2026 - 17h29

INVENTIVA news: financial news, earnings, stock moves and analysts

Live news related to INVENTIVA stock (FR0013233012): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.

The latest financial news on INVENTIVA mainly cover M&A activity, share price moves et analyst notes. The stock trades at €3,19 on Euronext Paris, down 4,63% at the last update. This page lists the articles published on INVENTIVA stock to track the share price, company announcements and any item likely to influence market perception.

Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext
INVENTIVA
FR0013233012
Pharmaceuticals & Biotechnology / Biotechnology
3,19 € -4,63 %
High3,34 €
Low3,17 €
Last update : 30/10/2026 - 17:29:35 – Euronext Paris – 15 min delay.
Market closed

Latest INVENTIVA stock news

The Burgundy biotech specializing in fibrotic and metabolic diseases enjoys a sharp rebound in mid-morning trading. The stock ranks among the stronges…

The Burgundy biotech specializing in fibrotic and metabolic diseases is falling sharply in mid-morning trading, as the Paris market itself declines. T…

The Burgundy biotech company specializing in fibrotic and metabolic diseases is recovering at midday, within a Paris index advancing modestly. This re…

The Burgundy biotech specializing in fibrotic and metabolic diseases resumes its downward slide at midday, while the Paris index remains virtually sta…

The Burgundy biotech company specializing in fibrotic and metabolic diseases is losing ground at midday, while the SBF 120 advances slightly. The stoc…

The Burgundy-based biotech specializing in fibrotic and metabolic diseases rises slightly at midday, in a nearly stable SBF 120. This rebound comes af…

The Burgundy-based biotech specializing in fibrotic and metabolic diseases is moving forward mid-morning, in a rising SBF 120. This renewed activity c…

The Burgundy-based biotech specializing in fibrotic and metabolic diseases is falling back midday, within an SBF 120 itself in decline. The stock rema…

The Burgundy biotech company specializing in fibrotic and metabolic diseases is declining again at mid-day, just days after losing a significant porti…

The Burgundy-based biotech company specializing in fibrotic and metabolic diseases suffers a sharp reversal this Thursday, after a rebound that had pr…

Ad
Chaque matin
Les signaux techniques du marché,
avant l'ouverture.
CAC 40 · SBF 120 · Signaux · Analystes
🤖
Édition du jour — avant bourse
CAC 40
7 702
-0,87%
SBF 120
5 827
-0,87%
📈 Signaux haussiers
+5,2%
+1,8%
+0,9%
📉 Signaux baissiers
-14%
-5,7%
🔄 Avis analystes
▲ 35 €
▼ 80 €
Inscrivez-vous pour tout voir →
Avant 9h chaque matin
Données Euronext
Analyse automatique IA